Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valerio Nardone

Showing results (31-40 of 139) with videos related to

Pageof 14
Sort By:
Quantitative Imaging in Medicine and Surgery|September 14, 2018
The role of delta radiomics in gastric cancerMaria Antonietta Mazzei, Valerio Nardone, Letizia Di Giacomo, et al.
Cancers|July 24, 2021
Radiomics in the Setting of Neoadjuvant Radiotherapy: A New Approach for Tailored TreatmentValerio Nardone, Luca Boldrini, Roberta Grassi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 30, 2016
Texture analysis of parotid gland as a predictive factor of radiation induced xerostomia: A subset analysisValerio Nardone, Paolo Tini, Christophe Nioche, et al.
Biomed Research International|November 22, 2017
Patients Affected by Unmethylated O(6)-Methylguanine-DNA Methyltransferase Glioblastoma Undergoing Radiochemotherapy May Benefit from Moderately Dose-Escalated RadiotherapyPaolo Tini, Valerio Nardone, Pierpaolo Pastina, et al.
Annals of Gastroenterology|March 23, 2026
Diffusion-weighted imaging increases the diagnostic performance of magnetic resonance imaging in assessing rectal cancer T stage and reduces intra- and interobserver variabilityAlfredo Clemente, Fabrizio Urraro, Gabriella Teresa Capolupo, et al.
Clinical Neurology and Neurosurgery|July 21, 2019
Is a reduction of radiation dose feasible in patients affected by glioblastoma undergoing radio-chemotherapy according to MGMT promoter methylation status without jeopardizing survival?Paolo Tini, Valerio Nardone, Pierpaolo Pastina, et al.
Immunotherapy|December 24, 2019
Could PD-1/PDL1 immune checkpoints be linked to HLA signature?Pierpaolo Correale, Rita E Saladino, Valerio Nardone, et al.
Clinical and Translational Radiation Oncology|April 10, 2024
All for one: Collaboration between dermatologist, radiation oncologist and radiologist in the clinical management of "difficult to treat" non melanoma skin cancerFederico Gagliardi, Anna Russo, Camila Scharf, et al.
Journal of Clinical Medicine|February 11, 2021
Endorectal Ultrasound and Magnetic Resonance Imaging for Rectal Cancer Staging: A Modern Multimodality ApproachAlfonso Reginelli, Alfredo Clemente, Angelo Sangiovanni, et al.
Medical Oncology (Northwood, London, England)|September 7, 2022
A critical review on oligometastatic disease: a radiation oncologist's perspectivePietro Pacifico, Riccardo Ray Colciago, Francesca De Felice, et al.
Pageof 14

Showing results (31-40 of 139) with videos related to

Sort By:
Pageof 14
Quantitative Imaging in Medicine and Surgery|September 14, 2018
The role of delta radiomics in gastric cancerMaria Antonietta Mazzei, Valerio Nardone, Letizia Di Giacomo, et al.
Cancers|July 24, 2021
Radiomics in the Setting of Neoadjuvant Radiotherapy: A New Approach for Tailored TreatmentValerio Nardone, Luca Boldrini, Roberta Grassi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 30, 2016
Texture analysis of parotid gland as a predictive factor of radiation induced xerostomia: A subset analysisValerio Nardone, Paolo Tini, Christophe Nioche, et al.
Biomed Research International|November 22, 2017
Patients Affected by Unmethylated O(6)-Methylguanine-DNA Methyltransferase Glioblastoma Undergoing Radiochemotherapy May Benefit from Moderately Dose-Escalated RadiotherapyPaolo Tini, Valerio Nardone, Pierpaolo Pastina, et al.
Annals of Gastroenterology|March 23, 2026
Diffusion-weighted imaging increases the diagnostic performance of magnetic resonance imaging in assessing rectal cancer T stage and reduces intra- and interobserver variabilityAlfredo Clemente, Fabrizio Urraro, Gabriella Teresa Capolupo, et al.
Clinical Neurology and Neurosurgery|July 21, 2019
Is a reduction of radiation dose feasible in patients affected by glioblastoma undergoing radio-chemotherapy according to MGMT promoter methylation status without jeopardizing survival?Paolo Tini, Valerio Nardone, Pierpaolo Pastina, et al.
Immunotherapy|December 24, 2019
Could PD-1/PDL1 immune checkpoints be linked to HLA signature?Pierpaolo Correale, Rita E Saladino, Valerio Nardone, et al.
Clinical and Translational Radiation Oncology|April 10, 2024
All for one: Collaboration between dermatologist, radiation oncologist and radiologist in the clinical management of "difficult to treat" non melanoma skin cancerFederico Gagliardi, Anna Russo, Camila Scharf, et al.
Journal of Clinical Medicine|February 11, 2021
Endorectal Ultrasound and Magnetic Resonance Imaging for Rectal Cancer Staging: A Modern Multimodality ApproachAlfonso Reginelli, Alfredo Clemente, Angelo Sangiovanni, et al.
Medical Oncology (Northwood, London, England)|September 7, 2022
A critical review on oligometastatic disease: a radiation oncologist's perspectivePietro Pacifico, Riccardo Ray Colciago, Francesca De Felice, et al.
Pageof 14